#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Congenital Adrenal Hyperplasia in Adults


Authors: Jana Vrbíková
Authors place of work: Endokrinologický ústav, Praha
Published in the journal: Vnitř Lék 2016; 62(Suppl 3): 131-134
Category: Reviews

Summary

Congenital adrenal hyperplasia is a life-long disease requiring an integrated therapy. It may negatively influence the quality of life. In childhood, the main problems of the care of these patients involve sex determination and ensuring optimum growth and puberty. The therapeutic goals for adults are the prevention of Addisonian crisis and ensuring the best possible quality of life, including fertility.

Key words:
androgens – cardiovascular risk – congenital adrenal hyperplasia – bone density – testicular rest tumors


Zdroje

1. Ogilvie CM, Crouch NS, Rumsby G et al. Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues. Clin Endocrinol (Oxf) 2006; 64(1): 2–11.

2. Speiser PW, Azziz R, Baskin LS et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95(9): 4133–4160. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2009–2631>.

3. Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005; 365(9477): 2125–2136.

4. Debono M, Mallappa A, Gounden V et al. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers. Eur J Endocrinol 2015; 173(6): 727–737. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-15–0064>.

5. King JA, Wisniewski AB, Bankowski BJ et al. Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91(3): 865–869.

6. Jaaskelainen J, Voutilainen R. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1996; 45(6): 707–713.

7. Guo CY, Weetman AP, Eastell R. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 1996; 45(5): 535–541.

8. Arlt W, Willis DS, Wild SH et al. Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients. J Clin Endocrinol Metab 2010; 95(11): 5110–5121. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2010–0917>.

9. Christiansen P, Molgaard C, Muller J. Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2004; 61(3): 133–136.

10. Kim MS, Merke DP. Cardiovascular disease risk in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Semin Reprod Med 2009; 27(4): 316–321. Dostupné z DOI: <http://dx.doi.org/10.1055/s-0029–1225259>.

11. Falhammar H, Filipsson H, Holmdahl G et al. Metabolic profile and body composition in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2007; 92(1): 110–116.

12. Gastaud F, Bouvattier C, Duranteau L et al. Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2007; 92(4): 1391–1396.

13. Bidet M, Bellanne-Chantelot C, Galand-Portier MB et al. Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2010; 95(3): 1182–1190. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2009–1383>.

14. Lo JC, Grumbach MM. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30(1): 207–229.

15. Lekarev O, Lin-Su K, Vogiatzi MG. Infertility and Reproductive Function in Patients with Congenital Adrenal Hyperplasia: Pathophysiology, Advances in Management, and Recent Outcomes. Endocrinol Metab Clin North Am 2015; 44(4): 705–722. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ecl.2015.07.009>.

16. Hagenfeldt K, Janson PO, Holmdahl G et al. Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod 2008; 23(7): 1607–1613. Dostupné z DOI: <http://dx.doi.org/10.1093/humrep/den118>.

17. Bouvattier C, Esterle L, Renoult-Pierre P et al. Clinical Outcome, Hormonal Status, Gonadotrope Axis, and Testicular Function in 219 Adult Men Born With Classic 21-Hydroxylase Deficiency. A French National Survey. J Clin Endocrinol Metab 2015; 100(6): 2303–2313. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–4124>.

18. Falhammar H, Nystrom HF, Ekstrom U et al. Fertility, sexuality and testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia. Eur J Endocrinol 2012; 166(3): 441–449. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-11–0828>.

19. Falhammar H, Frisen L, Hirschberg AL et al. Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. J Clin Endocrinol Metab 2015; 100(9): 3520–3528. Dostupné z DOI: <http://dx.doi.org/10.1210/JC.2015–2093>.

20. Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015; 172(3): R115-R124. Dostupné z DOI: <http://dx.doi.org/10.1530/EJE-14–0824>.

21. Claahsen-van der Grinten HL, Stikkelbroeck NM, Otten BJ et al. Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adult hood. Pharmacol Ther 2011; 132(1): 1–14. Dostupné z DOI: <http://dx.doi.org/10.1016/j.pharmthera.2011.05.004>.

22. Mallappa A, Sinaii N, Kumar P et al. A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2015; 100(3): 1137–1145. Dostupné z DOI: <http://dx.doi.org/10.1210/jc.2014–3809>.

23. New MI. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 2006; 91(11): 4205–4214.

24. Witchel SF, Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010; 2010: 625105. Dostupné z DOI: <http://dx.doi.org/10.1155/2010/625105>

Štítky
Diabetology Endocrinology Internal medicine

Článok vyšiel v časopise

Internal Medicine

Číslo Suppl 3

2016 Číslo Suppl 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#